Erdrich wins her first National Book Award

NEW YORK (AP) — The National Book Awards honored both longtime writers and new authors, from Louise Erdrich for "The Round House" to Katherine Boo for her debut work, "Beyond the Beautiful Forevers."

Erdrich, 58, has been a published and highly regarded author for nearly 30 years but had never won a National Book Award until being cited Wednesday for her story, the second of a planned trilogy, about an Ojibwe boy and his quest to avenge his mother's rape. A clearly delighted and surprised Erdrich, who's part Ojibwe, spoke in her tribal tongue and then switched to English as she dedicated her fiction award to "the grace and endurance of native people."

The works of two other winners also centered on young boys — Boo's for nonfiction, and William Alexander's fantasy "Goblin Secrets," for young people's literature. David Ferry won for poetry.

Boo's book, set in a Mumbai slum, is the story of a boy and his harsh and illuminating education in the consequences of crime or perceived crime. The author, a Pulitzer Prize-winning journalist currently on staff with The New Yorker, said she was grateful for the chance to live in a world she "didn't know" and for the chance to tell the stories of those otherwise ignored. She praised a fellow nominee and fellow Pulitzer-winning reporter, the late Anthony Shadid, for also believing in stories of those without fame or power.

Boo was chosen from one of the strongest lists of nonfiction books in memory, from the fourth volume of Robert Caro's Lyndon Johnson series to Shadid's memoir "House of Stone." Finalists in fiction, which in recent years favored lesser known writers, included such established names as Dave Eggers and Junot Diaz. Publishers have been concerned that the National Book Awards have become too insular and are considering changes, including expanding the pool of judges beyond writers.

Winners, chosen by panels of their peers, each will receive $10,000.Judges looked through nearly 1,300 books.

Ferry is a year older than one of the night's honorary recipients, Elmore Leonard. Ferry, 88, won for "Bewilderment: New Poems and Translations," a showcase for his versatile style. He fought back tears as he confided that he thought there was a chance for winning because he "was so much older" than the other nominees. Attempting to find poetry in victory, he called the award a "pre-posthumous" honor.

Alexander quoted fellow fantasy writer Ursula K. Le Guin in highlighting the importance of stories for shaping kids' imaginations and making the world a larger place than the one they live in.

"We have to remember that," Alexander said.

The ceremony was hosted by commentator-performer Faith Salie and went smoothly even though Superstorm Sandy badly damaged the offices of the award's organizer, the National Book Foundation, whose staffers had to work with limited telephone and mail access.

Honorary prizes were given to Leonard and New York Times publisher and chairman Arthur O. Sulzberger Jr.

Read More..

Alzheimer’s Tied to Mutation Harming Immune Response

Alzheimer’s researchers and drug companies have for years concentrated on one hallmark of Alzheimer’s disease: the production of toxic shards of a protein that accumulate in plaques on the brain.

But now, in a surprising coincidence, two groups of researchers working from entirely different starting points have converged on a mutated gene involved in another aspect of Alzheimer’s disease: the immune system’s role in protecting against the disease. The mutation is suspected of interfering with the brain’s ability to prevent the buildup of plaque.

The discovery, researchers say, provides clues to how and why the disease progresses. The gene, known as TREM2, is only the second found to increase Alzheimer’s risk substantially in older people.

“It points very specifically to a potential metabolic pathway that you could intervene in to change the course of Alzheimer’s disease,” said William Thies, chief medical and scientific officer of the Alzheimer’s Association.

Much work remains to be done before scientists understand precisely how the newly discovered gene mutation leads to Alzheimer’s, but already there are some indications from studies in mice. When the gene is not mutated, white blood cells in the brain spring into action, gobbling up and eliminating the plaque-forming toxic protein, beta amyloid. As a result, Alzheimer’s can be staved off or averted.

But when the gene is mutated, the brain’s white blood cells are hobbled, making them less effective in their attack on beta amyloid.

People with the mutated gene have a threefold to fivefold increase in the likelihood of developing Alzheimer’s disease in old age.

The intact gene, says John Hardy of University College London, “is a safety net.” And those with the mutation, he adds, “are living life without a safety net.” Dr. Hardy is lead author of one of the papers.

The discovery also suggests that a new type of drug could be developed to enhance the gene’s activity, perhaps allowing the brain’s white blood cells to do their work.

“The field is in desperate need of new therapeutic agents,” said Alison Goate, an Alzheimer’s researcher at Washington University in St. Louis who contributed data to Dr. Hardy’s study. “This will give us an alternative approach.”

The fact that two research groups converged on the same gene gives experts confidence in the findings. Both studies were published online Wednesday in The New England Journal of Medicine. “Together they make a good case that this really is an Alzheimer’s gene,” said Gerard Schellenberg, an Alzheimer’s researcher at the University of Pennsylvania who was not involved with the work.

The other gene found to raise the odds that a person will get Alzheimer’s, ApoE4, is much more common and confers about the same risk as the mutated version of TREM2. But it is still not clear why ApoE4, discovered in 1993, makes Alzheimer’s more likely.

Because the mutations in the newly discovered gene are rare, occurring in no more than 2 percent of Alzheimer’s patients, it makes no sense to start screening people for them, Dr. Thies said. Instead, the discovery provides new clues to the workings of Alzheimer’s disease.

To find the gene, a research group led by Dr. Kari Stefansson of deCODE Genetics of Iceland started with a simple question.

“We asked, ‘Can we find anything in the genome that separates those who are admitted to nursing homes before the age of 75 and those who are still living at home at 85?’ ” he said.

Scientists searched the genomes of 2,261 Icelanders and zeroed in on TREM2. Mutations in that gene were more common among people with Alzheimer’s, as well as those who did not have an Alzheimer’s diagnosis but who had memory problems and might be on their way to developing Alzheimer’s.

The researchers confirmed their results by looking for the gene in people with and without Alzheimer’s in populations studied at Emory University, as well as in Norway, the Netherlands and Germany.

The TREM2 connection surprised Dr. Stefansson. Although researchers have long noticed that the brain is inflamed in Alzheimer’s patients, he had dismissed inflammation as a major factor in the disease.

“I was of the opinion that the immune system would play a fairly small role, if any, in Alzheimer’s disease,” Dr. Stefansson said. “This discovery cured me of that bias.”

Meanwhile, Dr. Hardy and Rita Guerreiro at University College London, along with Andrew Singleton at the National Institute on Aging, were intrigued by a strange, rare disease. Only a few patients had been identified, but their symptoms were striking. They had crumbling bones and an unusual dementia, sclerosing leukoencephalopathy.

“It’s a weird disease,” Dr. Hardy said.

He saw one patient in her 30s whose brain disease manifested in sexually inappropriate behavior. Also, her bones kept breaking. The disease was caused by mutations that disabled both the copy of TREM2 that she had inherited from her mother and the one from her father.

Eventually the researchers searched for people who had a mutation in just one copy of TREM2. To their surprise, it turned out that these people were likely to have Alzheimer’s disease.

They then asked researchers around the world who had genetic data from people with and without Alzheimer’s to look for TREM2 mutations.

“Sure enough, they had good evidence,” Dr. Hardy said. The mutations occurred in one-half of 1 percent of the general population but in 1 to 2 percent of patients with Alzheimer’s disease.

“That is a big effect,” Dr. Hardy said.

Read More..

Staying smart about end-of-year healthcare

November is one of the most important months for health benefits. And it's half over.

This month is a time of open enrollment, when many workers sign up for next year's health insurance. Deadlines are a big deal, and you don't want to miss one.

But once you're set for 2013, experts say, shift your attention back to 2012 and those use-'em-or-lose-'em benefits awaiting you.

"Anything employees can do to accelerate elective care at year end allows them to get the full benefit" of their health plans, says Mike Thompson of consulting firm PricewaterhouseCoopers.

Here is a look at ways experts recommend to avoid leaving money on the table.

Make the most of your deductibles. Deductibles — the money you're required to pay out of pocket before insurance covers all or part of your healthcare services — are becoming more prevalent and more expensive.

If you've met your annual deductible for 2012, now may be a good time to schedule any medical treatment you've been delaying.

"At the beginning of the calendar year, everything resets with new out-of-pocket limits and deductibles. It's better to get any discretionary services done by the end of the year so you're in benefit and can get expenses reimbursed," Thompson says.

Today, a person with single coverage pays $1,097 on average in medical bills before insurance kicks in. According to Menlo Park, Calif.-based Kaiser Family Foundation, 72% of workers enrolled in an employer plan are on the hook for a deductible, up from about half in 2006. The amount of deductibles has also risen 88% during the same period.

And don't forget the possible savings of ordering prescription drugs before year end. You may be able to order a 90-day supply now to get you through the first few months of the year.

"It may make sense to accelerate your purchases of prescription drugs toward the end of the year because you know you're going to need them and they won't be subject to the deductible," Thompson says.

Be careful with your calculations. It should be easy to determine whether you've met your deductible for the year. But it can get tricky when you consider a lag, sometimes months long, between the time your doctor submits a claim and your insurance company processes it. You and your insurer may not have the same tally with regard to how much you've spent during this benefit year.

"My recommendation is to work with your broker's office to get an accurate assessment as to where you are in your benefit," says Dave Morgan, senior employee benefits advisor with Morris and Garritano Insurance Services in San Luis Obispo.

If you get health insurance at work, talk with your benefits or human resources department for assistance.

Coordinate your care. There's a caveat to the recommendation that you squeeze in care before New Year's Day. Consider first, Morgan says, the "choreography" of your care and how that may affect costs.

For example, knee surgery is likely to require months of follow-up physical therapy. Would it be less expensive to have your surgery fully covered in 2012 and pay cash for your physical therapy starting in 2013 before your deductible is met? Or, might holding off on the surgery until early 2013 result in less cash out of your pocket given the overall course of treatment?

To reap the greatest benefit from your health plan, do the math on both scenarios.

Splitting care between one year and the next can make sense, especially for dentistry. Dental plans typically come with an annual maximum benefit of $1,000 to $1,500. If you're in need of an expensive procedure, it may make financial sense to get started in December and finish in January.

"There's no perfect way to navigate all of this," says Martin Rosen, executive vice president of Health Advocate, a patient advocacy organization based in Pennsylvania. The key, Rosen says, is to "understand how your particular plan works and the leverage points throughout the year for which timing does make a difference."

Use your annual benefits. Be sure to take advantage of benefits with calendar limits, such as semi-annual dental cleanings, free eyeglasses or contact lenses. The same goes for preventive health services.

"When you get that preventive care, you're going to have a sense of what issues you'll face with your health in the coming year," Morgan says. That may better inform your 2013 health benefit choices as well as how much money to set aside in a Flexible Spending Account, or FSA, for next year.

Use all your FSA money. Unlike Health Savings Accounts, or HSAs, which allow you to roll over pretax dollar savings from one year to the next, FSAs have a shelf life. Typically you need to fully spend the account by year's end or you'll lose the money left over.

On average, people forfeit about $120 each year, says Jody Dietel, chief compliance officer at San Mateo, Calif.-based WageWorks, which administers employer-based tax advantaged accounts.

The IRS allows a grace period of 2 1/2 months, or by mid-March of the following year, to spend FSA money. And, according to Dietel, 75% of her company's 22,000 employer clients offer employees a grace period. But the length of time varies widely among employers, so check with your plan administrator to learn what's allowed.

Also, keep in mind that some rules have recently changed because of health reform. "For example, with an FSA you can't get over-the-counter drugs without a prescription from the doctor," Rosen says. To see a list of eligible expenses, go to the FSA Store at http://www.fsastore.com and click on the eligibility list at the bottom of the home page.

Many people lose money simply by failing to claim the expenses they already have, Dietel says. "Go and see if there is unfound money someplace," she says.

For example, if you fill all your prescriptions at the same pharmacy, ask the pharmacist to print a list of the co-pays for this year, and submit any outstanding charges to your Flexible Spending Account.

One final piece of advice before you pick up the phone to schedule your end-of-year doctor visit: Follow your health plan's rules, Morgan says. Stay in your health plan's network of doctors and hospital, and "make sure you have the proper pre-authorization in place."

business@latimes.com

Read More..

If soldier killed Afghan civilians in rampage, did he act alone?

JOINT BASE LEWIS MCCHORD, Wash. — The case against U.S. Army Staff Sgt. Robert Bales appeared at first to be horribly simple: Days after a bomb blew off the leg of a friend in southern Afghanistan, the 39-year-old combat veteran picked up his rifle, a pistol and a grenade launcher, walked to two villages and allegedly conducted a one-man campaign of vengeance, killing 16 civilians and wounding six more.

But by the time a weeklong hearing wound up Tuesday in a military courtroom, one of the Army's highest-profile war crimes from Afghanistan raised almost as many questions as it answered.

If Bales acted alone, why were shots heard coming from one of the villages 20 minutes after he was spotted returning to the base for the first time?

Why was a witness who claimed to have seen two U.S. soldiers killing her husband while helicopters flew overhead not brought in to testify?

Why were the crime scenes so very different — at one house, a surgical execution of the head of the family, while at the next house, 11 men, women and children were shot and possibly stabbed, their bodies piled in a heap and burned?

The Article 32 hearing, held to determine whether there was evidence to hold the serviceman for a court-martial, drew a portrait not just of a rogue soldier, defense lawyers said. It revealed a U.S. combat outpost at which soldiers spent their evenings drinking alcohol, snorting Valium and taking steroids, all three of which Bales apparently had done before asking a friend to "take care of my kids" and setting out into the darkness outside the base perimeter, laughing.

"We have a dysfunctional, drinking and drugging … team," civilian defense lawyer Emma Scanlan said in her closing argument.

"We can't isolate Sgt. Bales within a bubble," Scanlan said, noting that he was under the supervision of Special Forces officers. "They are the command. They are in charge. And they are terrible at it."

Army prosecutors claim Bales acted alone and with chilling rationality: walking to the village of Alkozai, where he is accused of killing four people and wounding six, coming back to the base and telling a friend what he had done, then venturing out again to the village of Najiban, where he is accused of killing 12.

When Bales returned to Camp Belambay the second time, he admitted to friends he had done some "sick" things, and told them they would thank him when fighting season got underway again during warmer weather later in the spring, said prosecutor Maj. Robert Stelle.

"Terrible, terrible things happened. That is clear. The second thing that is clear is that Staff Sgt. Bales did it," Stelle said.

He urged investigating officer Col. Lee Deneke to recommend a full court-martial and that it be tried as a capital case, with the possibility of the death penalty. Bales committed "the worst, most despicable crime a human being can commit: murdering children in their own homes," Stelle said.

If Deneke recommends a court-martial, a lengthy process of mental health evaluations and further forensic reports will follow. Defense lawyers have pledged there will be a full exploration of the medical care Bales received at the Madigan Army Medical Center for an earlier traumatic brain injury.

The hospital south of Seattle was the subject of an investigation this year for tossing aside diagnoses of post-traumatic stress disorder, making it harder for those soldiers to receive follow-up medical care.

In the year before the shootings, Scanlan said, Bales had received an exemplary evaluation, in which he was praised for "a strong moral compass, never wavering from what was right."

What went wrong?

Scanlan suggested part of the answer might lie in the steroids and sleep aids Bales was taking, along with the Jack Daniels he drank with two friends on the evening before the killings as they watched "Man on Fire," a movie about a former CIA operative who executes a violent campaign of revenge.

"They drank a ton, and they were all drunk," Scanlan said, noting that testimony showed that one of the soldiers who'd been drinking with Bales that night, Cpl. David Godwin, was stumbling, slurring his words and smelled like alcohol four hours later.

The prosecution said Bales had plenty of time to reach both villages and return at the end of the night with his clothing and weapons covered in blood. Before he left, prosecutors said, he had discussed his frustration with the Army's lack of response to the bomb that blew off his friend's leg; after his arrest, he reminded one soldier of an Afghan machine gunner the unit had faced earlier.

"That's not going to happen again," Bales said, according to Staff Sgt. Ross O'Rourke.

Prosecutors also established that DNA from at least one of the women killed at the home of Haji Mohammed Wazir in Najiban was found on Bales' clothing.

Yet defense lawyers continue to raise questions about whether Bales was the only one responsible — whether one person could have killed so many people in so many locations in one night.

A lot of the evidence suggests otherwise, Scanlan said, pointing to an agent from the Army's Criminal Investigations Command who said that Masuma Dawood, whose husband was shot, told her that two soldiers had killed her husband.

Army officials said Dawood did not testify because of "cultural differences," and the reluctance of Afghan families to allow a woman to testify in an American courtroom, even by remote video from Afghanistan. But sources in Afghanistan have told the Los Angeles Times that Dawood was, in fact, willing to testify.

Scanlan said the timeline laid out by prosecutors also raises questions, beginning with the Afghan guard who testified that he checked his watch, and was certain that the U.S. soldier he saw — returning from the initial killings in Alkozai, prosecutors allege — had returned to Camp Belambay at 1:30 a.m.

The shots heard from the direction of Alkozai didn't stop till 1:50 a.m., the defense attorney said.

"I don't know what that means," Scanlan said. "But one thing it means is, if you believe what the government is telling you, that Sgt. Bales is the one who came back through that wire at 1:30, then somebody else was firing for another 20 minutes."

kim.murphy@latimes.com

Read More..

Guilty plea expected by reputed Conn. mobster

HARTFORD, Conn. (AP) — A 76-year-old reputed Connecticut mobster is expected to plead guilty in a weapons and prescription drugs case that has revealed the FBI's belief that he has information about the largest art heist in history.

Robert Gentile, of Manchester, has a change-of-plea hearing scheduled in Hartford federal court on Wednesday. He has pleaded not guilty to allegations he illegally possessed firearms and explosives and sold illegally obtained prescription drugs.

It's not clear whether there is a plea deal. Gentile's lawyer and a spokesman for the U.S. attorney's office declined to comment about the hearing.

Gentile hasn't been charged in the museum theft. His attorney, A. Ryan McGuigan, has said his client knows nothing about the heist and isn't a Mafia member.

At a court hearing in March, Assistant U.S. Attorney John Durham said the FBI believes Gentile "had some involvement in connection with stolen property" related to a 1990 heist at Boston's Isabella Stewart Gardner Museum.

Thieves disguised as police officers struck as the city finished celebrating St. Patrick's Day, tying up two guards and making off with 13 pieces of art including masterworks by Rembrandt, Vermeer, Degas and Manet worth more than a half-billion dollars. The artwork hasn't been found and the museum is still offering a $5 million reward.

Durham has said that FBI agents had unproductive discussions with Gentile about the theft, but he didn't elaborate on his allegations. Durham also said the FBI believes Gentile is a made member of a Philadelphia crime family.

Gentile has been detained since February when he and an associate, Anthony Parente, were charged with selling illegally obtained prescription drugs including OxyContin, Dilaudid and Percocet.

Authorities searched Gentile's home and reported finding homemade dynamite sticks, several guns, ammunition, homemade silencers, a bulletproof vest, handcuffs, police scanners, brass knuckles and $22,000 in cash at the bottom of a grandfather clock.

Federal agents swarmed Gentile's home again in May in what McGuigan called a veiled attempt to find the stolen paintings. McGuigan said at the time that the FBI got a new warrant allowing the use of ground-penetrating radar to look for buried weapons, but he believed they really were looking for the artwork.

"This is nonsense," McGuigan said in May. "This is the FBI. Are you trying to tell me they missed something the first time? They're trying to find $500 million of stolen artwork. ... All they're going to find is night crawlers."

All McGuigan would say on Tuesday was that Gentile has been confined in a cell by himself and "looks terrible."

"They have him in a hole 24 hours a day where he can't see anybody," McGuigan said.

Gentile is charged with three weapons crimes that each carry up to 10 years in prison and six drug crimes that carry up to 20 years in prison apiece. He wasn't supposed to have any guns because of a 1990s larceny conviction.

The drug case against Parente remains pending. He is free on bail.

Read More..

Recipes for Health: Roasted Eggplant and Chickpeas — Recipes for Health

Andrew Scrivani for The New York Times

Eggplant is always a good, substantial vegetable to use for a vegetarian main dish. The chickpeas and the feta provide plenty of protein. Vegans can leave out the feta and substitute sugar or agave nectar for the honey.

 

1/4 cup extra virgin olive oil

2 garlic cloves, minced

1 28-ounce can chopped tomatoes, with juice, pulsed to a coarse purée

1 teaspoon mild honey (more to taste)

1/4 to 1/2 teaspoon cinnamon, to taste

Salt to taste

1 large or 2 medium eggplants (about 1 1/4 pounds), cut into 1/3-inch-thick slices

3 cups cooked chickpeas (2 cans, drained and rinsed, or, 1 1/2 cups dried – about 3/4 pound

4 ounces feta, crumbled (3/4 cup)

1 teaspoon dried oregano, preferably Greek or Turkish

 

1. Make the tomato sauce. Heat 1 tablespoon of the olive oil in a heavy skillet or wide saucepan over medium heat, and add the garlic. Cook, stirring, until it smells fragrant, about 30 seconds, and add the tomatoes, honey, salt to taste and cinnamon. Cook over medium heat until the tomatoes have cooked down and the sauce is fragrant, about 20 minutes. Taste and adjust seasonings.

2. Meanwhile, heat the oven to 425 degrees. Line a baking sheet with aluminum foil and brush the boil with olive oil. Place the eggplant slices on the baking sheet, salt lightly and brush with olive oil. Place in the oven and bake 20 minutes, or until eggplant is lightly browned and soft all the way through. Remove from the heat. Fold the aluminum foil over and crimp the edges together so that the eggplant steams as it cools. Do this in batches if you need more than one baking sheet. Turn the oven down to 350 degrees.

3. Oil a 2-quart baking dish or gratin. Place the chickpeas in the baking dish and stir in 1 cup of the tomato sauce. Layer the eggplant over the chickpeas and top with the remaining tomato sauce. Sprinkle the feta over the top and drizzle on any remaining olive oil. Sprinkle with the oregano and cover tightly with foil. Bake 30 minutes. Uncover and bake another 10 minutes, until the dish is bubbling.

Yield: 6 servings

Advance preparation: The eggplant slices can be cooked up to a day ahead. Hold in the refrigerator, covered. The tomato sauce will keep for 3 days in the refrigerator and freezes well.

Nutritional information per serving: 366 calories; 16 grams fat; 4 grams saturated fat; 2 grams polyunsaturated fat; 8 grams monounsaturated fat; 17 milligrams cholesterol; 44 grams carbohydrates; 14 grams dietary fiber; 431 milligrams sodium (does not include salt to taste); 15 grams protein

Martha Rose Shulman is the author of “The Very Best of Recipes for Health

Read More..

McAfee proclaims innocence, alters look to evade Belize police

In another twist to an already bizarre story, the founder of the McAfee anti-virus software company contacted an American journalist Tuesday to maintain his innocence and chronicle how he has been evading police.

John McAfee, 67, has been missing since Sunday morning, when his next-door neighbor Gregory Faull, 52, was found dead in a pool of blood in a Belize beachfront home. On Tuesday, McAfee contacted Wired contributing editor Joshua Davis and said he's on the run, scared for his life — and did not commit murder.

Quiz: Test your knowledge about airport security

Belize police on Sunday said they wanted to question McAfee in what they described as a homicide investigation.

Davis tweeted the salient details, including the former CEO saying he feared being killed in custody and — when power was cut to his hiding spot — the grim summation that "this is it."

"Under no circumstances am I going to willingly talk to the police in this country," McAfee reportedly told the editor at the technology magazine. "You can say I'm paranoid about it but they will kill me, there is no question. They've been trying to get me for months. They want to silence me. I am not well liked by the prime minister. I am just a thorn in everybody's side."

As police raided his compound Sunday, McAfee told the writer that he hid in the sand with a cardboard box over his head so he could breathe, and spent the night on a mattress infested with lice. He has continued to change locations, according to the writer's tweets.

Quiz: Test your knowledge of business news

"It was extraordinarily uncomfortable," McAfee told Wired. "But they will kill me if they find me."

Belize police urged McAfee to come forward Tuesday, saying he is only a person of interest, rather than a murder suspect. The police said they have detained an individual but declined to discuss details, citing the ongoing investigation.

Police have a vendetta against him, McAfee told Wired, and are trying to drive him out of Belize.

McAfee made his fortune when the anti-virus company that bears his name went public in 1992. He netted $100 million two years later when he sold his stock. Over the next 20 years, $100 million dropped to $4 million as he lost money to real estate investments, bad business ventures and bonds linked to Lehman Bros.

About five years ago, McAfee moved to a beachfront compound on Ambergris Caye island to lower his taxes, said Daniel Guerrero, the mayor of the town closest to the crime scene.

Belize police arrested McAfee in April and charged him with unlicensed drug manufacturing and possession of an unlicensed weapon, according to police news releases. McAfee said at the time that he planned to sue for false arrest, alleging the police arrested him because he refused to donate money to a local official.

Last week, Faull — a retired contractor from Florida — filed a complaint against McAfee with the local city council, Guerrero said. McAfee's security guards were trespassing on Faull's property, and McAfee's guard dogs were attacking passers-by, Faull's complaint said.

Faull's two-story apartment showed no signs of forced entry. A laptop and iPhone were missing, and police found a 9-millimeter Luger shell casing on the stairs, spokesman Raphael Martinez said.

Police believe McAfee is still in the country but have had little success in tracking him down, perhaps due in part to the latest information he shared with Davis — that he has radically altered his appearance.

laura.nelson@latimes.com

Read More..

Prescription deaths: Lawmaker wants cases reported to Medical Board

« Previous Post | L.A. NOW Home

The chairman of a state Senate committee that oversees the Medical Board said Monday he would introduce a bill requiring coroners to report all prescription drug deaths to the agency — a move aimed at helping authorities identify doctors whose prescribing practices may be harming patients.

Sen. Curren D. Price Jr., responding to a Times' report that authorities have failed to recognize how often people overdose on medications prescribed by their doctors, said the medical board needed coroners reports to improve oversight of potentially dangerous practices.

“There appears to be a disconnect between coroners and the Medical Board,” Price (D-Los Angeles), said in an interview. “Hopefully legislation will tighten that up and provide the kind of accountability we all expect.”

FULL COVERAGE: Legal drugs, deadly outcomes

The Times investigation published Sunday found that in nearly half of the accidental deaths from prescription drugs in four Southern California counties, the deceased had a doctor's prescription for at least one drug that caused or contributed to the death.

The investigation identified 3,733 deaths that involved prescription drugs in Los Angeles, Orange, San Diego and Ventura counties from 2006 through 2011. In 1,762 of those cases — 47% — drugs for which the deceased had a prescription were the sole cause or a contributing cause of death.

The Times found that prescription drug deaths often involved multiple drugs, sometimes prescribed by more than one doctor. In some cases, the deceased also mixed prescribed drugs with illegal drugs, alcohol or both.

The paper identified 71 Southern California physicians who prescribed drugs to three or more patients who later fatally overdosed. The doctors were primarily pain specialists, general practitioners and psychiatrists.

Price said that although there may be legitimate reasons for a doctor's prescriptions being linked to a death, “it’s cause for some further review.”

“I think a red flag goes up any time you have one [doctor] involved in several deaths,” he said. “And I think an investigation is not only warranted but called upon by the public.”

Read More..

'Skyfall' brings record Bond debut of $88.4M

LOS ANGELES (AP) — James Bond is cashing in at the box office.

"Skyfall," the 23rd film featuring the British super-spy, pulled in a franchise-record $88.4 million in its U.S. debut, bringing its worldwide total to more than $500 million since it began rolling out overseas in late October.

The top 20 movies at U.S. and Canadian theaters Friday through Sunday, followed by distribution studio, gross, number of theater locations, average receipts per location, total gross and number of weeks in release, as compiled Monday by Hollywood.com are:

1. "Skyfall," Sony, $88,364,714, 3,505 locations, $25,211 average, $90,564,714, one week.

2. "Wreck-It Ralph," Disney, $33,012,796, 3,752 locations, $8,799 average, $93,647,405, two weeks.

3. "Flight," Paramount, $14,785,097, 2,047 locations, $7,223 average, $47,455,396, two weeks.

4. "Argo," Warner Bros., $6,617,229, 2,763 locations, $2,395 average, $85,583,187, five weeks.

5. "Taken 2," Fox, $4,012,829, 2,487 locations, $1,614 average, $131,300,000, six weeks.

6. "Cloud Atlas," Warner Bros., $2,658,250, 2,023 locations, $1,314 average, $22,844,956, three weeks.

7. "The Man With the Iron Fists," Universal, $2,592,705, 1,872 locations, $1,385 average, $12,821,030, two weeks.

8. "Pitch Perfect," Universal, $2,573,350, 1,391 locations, $1,850 average, $59,099,993, seven weeks.

9. "Here Comes the Boom," Sony, $2,522,790, 2,044 locations, $1,234 average, $39,033,885, five weeks.

10. "Hotel Transylvania," Sony, $2,400,226, 2,566 locations, $935 average, $140,954,208, seven weeks.

11. "Paranormal Activity 4," Paramount, $1,980,033, 2,348 locations, $843 average, $52,600,612, four weeks.

12. "Sinister," Summit, $1,524,448, 1,554 locations, $981 average, $46,578,686, five weeks.

13. "Silent Hill: Revelation," Open Road Films, $1,300,137, 1,902 locations, $684 average, $16,383,406, three weeks.

14. "The Perks of Being a Wallflower," Summit, $1,132,924, 607 locations, $1,866 average, $14,614,770, eight weeks.

15. "Lincoln," Disney, $944,308, 11 locations, $85,846 average, $944,308, one week.

16. "Alex Cross," Summit, $911,973, 1,090 locations, $837 average, $24,603,042, four weeks.

17. "Fun Size," Paramount, $757,223, 1,301 locations, $582 average, $8,800,336, three weeks.

18. "Looper," Sony, $582,150, 491 locations, $1,186 average, $64,669,383, seven weeks.

19. "The Sessions," Fox, $545,550, 128 locations, $4,262 average, $1,655,222, four weeks.

20. "Seven Psychopaths," CBS Films, $404,812, 356 locations, $1,137 average, $14,098,469, five weeks.

___

Universal and Focus are owned by NBC Universal, a unit of Comcast Corp.; Sony, Columbia, Sony Screen Gems and Sony Pictures Classics are units of Sony Corp.; Paramount is owned by Viacom Inc.; Disney, Pixar and Marvel are owned by The Walt Disney Co.; Miramax is owned by Filmyard Holdings LLC; 20th Century Fox and Fox Searchlight are owned by News Corp.; Warner Bros. and New Line are units of Time Warner Inc.; MGM is owned by a group of former creditors including Highland Capital, Anchorage Advisors and Carl Icahn; Lionsgate is owned by Lions Gate Entertainment Corp.; IFC is owned by AMC Networks Inc.; Rogue is owned by Relativity Media LLC.

___

Online:

http://www.hollywood.com

Read More..

Lance Armstrong Cuts Officials Ties With His Livestrong Charity

In the wake of being stripped of his seven Tour de France titles for doping, Lance Armstrong last week cut all official ties with Livestrong, the charity he founded 15 years ago while he was treated for testicular cancer.

On Nov. 4, he resigned from the organization’s board of directors; he had previously stepped down as the chairman of the board Oct. 17. He has distanced himself from the charity to try to protect it from any damage caused by his doping controversy, the new board chairman, Jeff Garvey, said in a statement.

“Lance Armstrong was instrumental in changing the way the world views people affected by cancer,” Garvey said. “His devotion to serving survivors is unparalleled, and for 15 years, he committed himself to that cause with all his heart.”

Garvey said that the Armstrong family had donated nearly $7 million to the foundation and that the organization under Armstrong had raised close to $300 million to serve cancer survivors.

Last month, the United States Anti-Doping Agency made public its evidence in its doping case against Armstrong, saying he had doped and encouraged his teammates to dope so they could help him win races. He was subsequently barred from Olympic sports for life and was stripped of all the cycling titles he won from August 1998 on.

Since then, Armstrong has spent several weeks in Hawaii, out of the public eye. On Saturday, though, he posted a photograph on Twitter showing him at home in Austin, Tex. He is lounging on a couch with his seven yellow Tour jerseys framed on the wall in the background.

In the post, he said, “Back in Austin and just layin’ around.” The photograph had more than 400,000 page views as of Monday evening, with many people posting negative comments on the page.

“Lance, you have no moral conscious and it’s obvious many of your followers don’t either,” said one person who went by the Twitter handle “irobot,” who also posted that Armstrong needed “professional help.”

A person posting under the name “Aumann” said: “An art thief enjoying all his da Vincis.”

Other people posted words of support, including many who said they still thought Armstrong was the top cyclist in history.

“TomShelton” said of Armstrong’s seven Tour titles, “You earned all 7 of them no matter what is being said about you!”

Read More..